GuidoTricotMD

PubMed

• A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.
  Wancheng Guo, Christopher Strouse, David Mery, Eric R Siegel, Manit N Munshi, Timothy Cody Ashby, Yan Cheng, Fumou Sun, Visanu Wanchai, Zijun Zhang, Clyde Bailey, Dais...> ;Cancers. 2024 Mar 11
• Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
  Guo, W., Zhan, Y., Mery, D., Siegel, E., Sun, F., Cheng, Y., Ashby, T., Zhang, Z., Bailey, C., Alapat, D., Peng, H., Hadidi, S., Thanendrarajan, S., Schinke, C., Zanga...> ;Blood Cancer Journal. 2024 Feb 14
• 1 citations
  Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.
  Al Hadidi, S., Bailey, C., Panozzo, S., Cottler-Fox, M., Shaughnessy, J., Zhan, F., van Rhee, F., Thanendrarajan, S., Barlogie, B., Zangari, M., Ababneh, O., Schinke, ...> ;Blood Advances. 2024 Feb 13
• 1 citations
  Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
  Sun, F., Cheng, Y., Wanchai, V., Guo, W., Mery, D., Xu, H., Gai, D., Siegel, E., Bailey, C., Ashby, C., Al Hadidi, S., Schinke, C., Thanendrarajan, S., Ma, Y., Yi, Q.,...> ;Nature Communications. 2024 Jan 19
• Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS.
  Wancheng Guo, Anne Zhan, David E Mery, Manit N Munshi, Oussama Makhoul, Clyde Baily, Maurizio Zangari, Guido Tricot, Hongling Peng, John D Shaughnessy Jr> ;Blood Advances. 2023 Nov 14
• BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
  Fumou Sun, Yan Cheng, Jin-Ran Chen, Visanu Wanchai, David E Mery, Hongwei Xu, Dongzheng Gai, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zang...> ;The Journal of Clinical Investigation. 2024 Jan 2
• Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.
  Christopher Strouse, Sarah L Mott, Brian J Smith, Margarida Magalhaes-Silverman, Umar Farooq, Fenghuang Zhan, Yogesh Jethava, Guido Tricot> ;Bone Marrow Transplantation. 2024 Jan 1
• 1 citations
  High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.
  Yan Cheng, Fumou Sun, Daisy V Alapat, Visanu Wanchai, David Mery, Wancheng Guo, Huojun Cao, Yuqi Zhu, Cody Ashby, Michael Anton Bauer, Intawat Nookaew, Eric R Siegel, ...> ;Cell Reports. Medicine. 2023 Oct 17
• 1 citations
  A gene signature can predict risk of MGUS progressing to multiple myeloma.
  Fumou Sun, Yan Cheng, Jun Ying, David Mery, Samer Al Hadidi, Visanu Wanchai, Eric R Siegel, Hongwei Xu, Dongzheng Gai, Timothy Cody Ashby, Clyde Bailey, Jin-Ran Chen, ...> ;Journal of Hematology & Oncology. 2023 Jun 29
• 22 citations
  Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
  Raghad Alqazaqi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John Shaughnessy Jr, Fenghuang Zhan, Guido Tricot, Frits van Rhee, Samer Al Hadidi> ;JAMA Network Open. 2022 Aug 1
• 10 citations
  CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.
  Dongzheng Gai, Jin-Ran Chen, James P Stewart, Intawat Nookaew, Hasem Habelhah, Cody Ashby, Fumou Sun, Yan Cheng, Can Li, Hongwei Xu, Bailu Peng, Tarun K Garg, Carolina...> ;The Journal of Clinical Investigation. 2022 Sep 15
• 2 citations
  Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
  Kristin Larsen, Horace Spencer, Meera Mohan, Clyde Bailey, Kerri Hill, Mathew Kottarathara, Richa Parikh, Shadiqul Hoque, Amani Erra, Angel A Mitma, Pankaj Mathur, Lak...> ;Journal of Clinical Medicine. 2022 Mar 16
• Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
  David Baker, Milan Bimali, Luis Carrillo, Archana Sachedina, Daisy Alapat, Md Shadiqul Hoque, Mathew Kottarathara, Richa Parikh, Amani Erra, Angel A Mitma, Pankaj Math...> ;Haematologica. 2021 Dec 1
• 11 citations
  Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma.
  Meera Mohan, Samantha Kendrick, Aniko Szabo, Naveen Yarlagadda, Dinesh Atwal, Yadav Pandey, Arya Mariam Roy, Richa Parikh, James Lopez, Sharmilan Thanendrarajan, Carol...> ;Blood Advances. 2021 Nov 22
• 9 citations
  Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
  Lakshmi Yarlagadda, Sravani Gundarlapalli, Richa Parikh, Reid D. Landes, Mathew Kottarathara, Yetunde Ogunsesan, Shadiqul Hoque, Angel A Mitma, Clyde Bailey, Kerri Hil...> ;Cancers. 2021 Aug 10
• 13 citations
  TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies
  Can Li, Jiliang Xia, Reinaldo Franqui-Machin, Fangping Chen, Yanjuan He, Timothy Cody Ashby, Feixiang Teng, Hongwei Xu, Dingxiao Liu, Dongzheng Gai, Sarah K. Johnson, ...> ;The Journal of Clinical Investigation. 2021 Jul 15
• 4 citations
  Persistent bone marrow minimal residual disease as a “high-risk” disease feature in multiple myeloma
  Meera Mohan, Aniko Szabo, Naveen Yarlagadda, Sravani Gundarlapalli, Sharmilan Thanendrarajan, Samantha Kendrick, Carolina Schinke, Daisy Alapat, Jeffrey R. Sawyer, Erm...> ;American Journal of Hematology. 2021 May 29
• 10 citations
  Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression.
  Can Li, Erik Wendlandt, Benjamin W. Darbro, Hongwei Xu, Gregory S. Thomas, Guido Tricot, Fangping Chen, John D. Shaughnessy, Fenghuang Zhan> ;Cancers. 2021 Jan 29
• 31 citations
  Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma
  Minjie Gao, Hua Bai, Yogesh Jethava, Yujie Wu, Yuqi Zhu, Ye Yang, Jiliang Xia, Huojun Cao, Reinaldo Franqui-Machin, Kalyan Nadiminti, Gregory S. Thomas, Mohamed E. Sal...> ;Journal of the National Cancer Institute. 2020 May 1
• 18 citations
  Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15a.
  Tengteng Yu, Chenxing Du, Xiaoke Ma, Weiwei Sui, Zhen Yu, Lanting Liu, Lei Zhao, Zhongqing Li, Jie Xu, Xiaojing Wei, Wen Zhou, Shuhui Deng, Dehui Zou, Gang An, Yu-Tzu ...> ;Molecular Cancer Research. 2020 Apr 20
• Therapeutic Advances in the Management of Smoldering Myeloma.
  Rafiullah Khan, Umar Zahid, Vidya Kollu, Nusrat Jahan, McBride Ali, Guido J Tricot, Faiz Anwer> ;American Journal of Therapeutics. 2020 Mar 1
• 24 citations
  A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.
  Yingcong Wang, Jing Huang, Bo Li, Han Xue, Guido Tricot, Liangning Hu, Zhijian Xu, Xiaoxiang Sun, Shuaikang Chang, Lu Gao, Yi Tao, Hongwei Xu, Yongsheng Xie, Wenqin Xi...> ;Cancer Research. 2020 Feb 1
• 2 citations
  Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
  Chunyan Gu, Xuefang Jing, Carol J. Holman, Ramakrishna Sompallae, Fenghuang Zhan, Guido Tricot, Ye Yang, Siegfried Janz> ;BMC Cancer. 2019 Dec 20
• A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma.
  Sabarinath Venniyil Radhakrishnan, Michael Boyer, Catherine M.T. Sherwin, Maurizio Zangari, Guido J Tricot> ;Cell Transplantation. 2019 Oct 16
• 6 citations
  Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.
  Mu Hao, Bart Barlogie, Guido Tricot, Lanting Liu, Lugui Qiu, John D. Shaughnessy, Fenghuang Zhan> ;Clinical Cancer Research. 2019 Jan 1
• Join now to see all

Journal Articles

• Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia  
  Guido Tricot, MD, Clinical Cancer Research

Abstracts/Posters

• Targeting NEK2 Induces Cellular Senescence in B-Cell Malignancies through p53-Independent Signaling Pathways
  Guido J. Tricot, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• TRIP13 Modulates Protein Deubiquitination to Promote Myeloma Progression
  Guido J. Tricot, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long-Term Outcome of Total Therapy Regimens: Impact of Molecular Subgroups
  Guido J. Tricot, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Early Intensive Therapy in Multiple Myeloma Using Tandem Transplantation with Novel Conditioning and Two Years Maintenance: A Single Institution Experience 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018